Step 1 topics → Musculoskeletal, Skin, and Connective Tissue → Psoriasis

Psoriasis

USMLE Step 1 trap: Misunderstands the histologic basis of the Auspitz sign in psoriasis. The Auspitz sign results from removal of the parakeratotic scale exposing the tips of elongated dermal papillae with dilated capillaries (suprapapillary thinning).

Psoriasis is a chronic immune-mediated inflammatory skin disease defined by hyperproliferation of keratinocytes driven by the Th17/IL-23 axis — and USMLE Step 1 tests it across dermatology, immunology, rheumatology, and pharmacology in a single vignette. Students who learned from older sources often call it a 'Th1 disease,' which is wrong and will cost them points on biologic mechanism questions. The classic presentation is well-demarcated, salmon-colored plaques with silvery scale on extensor surfaces (elbows, knees, scalp, sacrum).

The exam tests psoriasis from multiple angles. Presentation questions give you a skin description and ask you to identify the diagnosis or explain a clinical sign like Auspitz sign or Koebner phenomenon. Mechanism questions ask about the cytokine axis, the histologic findings (parakeratosis, acanthosis, Munro microabscesses), or why biologics like secukinumab (anti-IL-17) or ustekinumab (anti-IL-12/23) work. Association questions link psoriasis to psoriatic arthritis, metabolic syndrome, or cardiovascular disease. Management questions test the step-up ladder: topical steroids and vitamin D analogs first, then phototherapy (UVB), then systemic agents (methotrexate, cyclosporine), then biologics.

The trickiest parts are the misconceptions students carry in. Many memorize psoriasis as a 'Th1 disease' from older sources when the dominant axis is actually Th17/IL-23 — this matters because it explains the biologic targets. Students also misplace Munro microabscesses in the dermis (they're in the stratum corneum) and misread psoriatic arthritis as rheumatoid-like symmetric small-joint disease when it's actually asymmetric, DIP-dominant, and seronegative. Getting these distinctions right is what separates a passing score from a high one on USMLE Step 1.

From real student decks
62%have cards covering this topic
49%have mature cards

Common misconceptions

Common mistake
Wrong: The Auspitz sign (pinpoint bleeding on scale removal) reflects superficial erosion of normal skin.
Right: The Auspitz sign results from removal of the parakeratotic scale exposing the tips of elongated dermal papillae with dilated capillaries (suprapapillary thinning).
The Auspitz sign is not just superficial skin trauma. In psoriasis, the suprapapillary epidermis is markedly thinned while the dermal papillae are elongated and packed with dilated, tortuous capillaries. When you remove the parakeratotic scale, you're exposing those capillary tips directly — that's why you get discrete pinpoint bleeding spots rather than a diffuse ooze. Think of it as uncovering a forest of exposed blood vessels, not just scratching normal skin.
Common mistake
Wrong: Psoriasis is primarily a Th1-mediated disease because it involves IFN-γ.
Right: Psoriasis is primarily driven by the Th17/IL-23 axis; IL-17A and IL-22 are the key effector cytokines responsible for keratinocyte hyperproliferation.
Older immunology texts emphasized Th1 and IFN-γ in psoriasis, but the dominant axis is Th17/IL-23. Dendritic cells release IL-23, which drives Th17 differentiation; Th17 cells then release IL-17A and IL-22, which act on keratinocytes to cause the hyperproliferation and abnormal differentiation seen in plaques. This distinction is clinically critical: the most effective modern biologics (secukinumab, ixekizumab, ustekinumab) target IL-17 or IL-23, not IFN-γ — and USMLE Step 1 will ask you to match the drug to its target.
Common mistake
Wrong: Psoriatic arthritis is a symmetric small-joint polyarthritis identical to rheumatoid arthritis.
Right: Psoriatic arthritis classically causes asymmetric oligoarthritis with DIP joint involvement and dactylitis ('sausage digits'), and is seronegative (RF negative).
Psoriatic arthritis does not look like RA. The classic pattern is asymmetric oligoarthritis (fewer joints, not the same ones bilaterally) with prominent DIP involvement — the opposite of RA, which typically spares the DIPs. Dactylitis ('sausage digits' from inflammation of the entire digit) and enthesitis are hallmarks. Critically, psoriatic arthritis is seronegative: RF and anti-CCP are negative, which helps you rule out RA on a vignette.
Common mistake
Wrong: Munro microabscesses in psoriasis are located in the dermis.
Right: Munro microabscesses are collections of neutrophils within the stratum corneum (parakeratotic layer), a hallmark histologic finding of psoriasis.
Munro microabscesses are neutrophil collections within the stratum corneum — specifically in the parakeratotic layer where nuclei are retained abnormally. They are not dermal. This matters because their location is a direct consequence of the disease mechanism: chemokines released by inflamed keratinocytes recruit neutrophils upward into the epidermis. Knowing they're in the stratum corneum ties together the histology (parakeratosis + neutrophil migration) and is exactly the kind of detail a Step 1 histology image question will test.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the classic plaque morphology (well-demarcated salmon plaques, silvery scale, extensor distribution) and explain clinical signs like the Auspitz sign and Koebner phenomenon by their underlying mechanism.
  2. Identify the Th17/IL-23 axis as the primary driver of psoriasis, know IL-17A and IL-22 as key effector cytokines causing keratinocyte hyperproliferation, and connect this to the histologic hallmarks: parakeratosis, acanthosis, Munro microabscesses in the stratum corneum, and suprapapillary thinning.
  3. Recognize psoriatic arthritis as an asymmetric, seronegative oligoarthritis with DIP joint involvement and dactylitis, and distinguish it from rheumatoid arthritis; also connect psoriasis to its systemic comorbidities including metabolic syndrome and increased cardiovascular risk.
  4. Apply the step-up management ladder from topical agents (steroids, calcipotriene) to phototherapy (narrowband UVB) to systemic agents (methotrexate, cyclosporine, acitretin) to biologics (anti-TNF, anti-IL-17, anti-IL-23), and know which biologic targets which cytokine.

Can you avoid these mistakes?

A biopsy of a psoriatic plaque shows neutrophil collections in the outermost epidermal layer, retained nuclei in that same layer, and elongated rete ridges. Name the three histologic findings and identify where exactly the neutrophil collections are located.
A patient with known psoriasis develops pain and swelling in the right index finger DIP joint and left knee. RF and anti-CCP are negative. Her right index finger appears swollen along its entire length. What is the diagnosis, what is the name for the finger finding, and how does this differ from rheumatoid arthritis?
A dermatologist scrapes a psoriatic plaque and notes pinpoint bleeding at multiple discrete spots. Explain the histologic reason this occurs — what structure is being exposed and why does it bleed?
A patient with moderate-to-severe plaque psoriasis has failed topical steroids and narrowband UVB therapy. Her physician starts a biologic targeting the cytokine most responsible for keratinocyte hyperproliferation in psoriasis. Which cytokine is being targeted, which T-helper cell subset produces it, and name one drug in this class?

Related topics

Bone Cells and Matrix Endochondral vs Membranous Ossification Fracture Healing Stages Compartment Syndrome

See how your Anki deck covers this topic.

Upload your deck for a free audit →